Dedicated to life-saving therapies to address side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for bioterrorism agents.
Joined August 2009
- Tweets 32
- Following 0
- Followers 90
- Likes 0
Photos and videos
27 Sep 2010
Soligenix ($SNGX) Provides Corporate Update - Announces Election of Tamar D. Howson and Virgil D. Thompson to Board http://bit.ly/cbUubb
1
4
2 Sep 2010
Soligenix ($SNGX) Publication Identifying Domains Within the Ricin Toxin A Subunit as Targets of Protective Antibodies http://bit.ly/ag1XkU
2
23 Aug 2010
Soligenix ($SGNX) Announces Award of $1.2 Million FDA Orphan Products Development Grant http://www.soligenix.com/news.aspx?titleId=355
1
16 Aug 2010
Soligenix ($SGNX) Reports Second Quarter 2010 Financial Results and Reviews Accomplishments http://www.soligenix.com/news.aspx?titleId=354
1
29 Jun 2010
Soligenix ($SNGX) to Present at the OneMedForum Conference on Wednesday, June 30th at 2PM EDT http://bit.ly/aZzvw0
1
29 Jun 2010
Soligenix ($SNGX) to Present at the OneMedForum Conference in New York City on Wednesday, June 30th at 2PM EDT
1
25 Jun 2010
Soligenix $SNGX Publishes Positive Data on Protection from Ricin Intoxication by Intradermal RiVax™ Administration http://bit.ly/9f5n5O
1
16 Jun 2010
Soligenix $SNGX Announces Financing of $5.16 Million with its Partner Sigma-Tau and other Institutional Investors http://bit.ly/czkUQ8
1
3 Jun 2010
Soligenix $SNGX Announces Grant of European Patent for the Treatment of GVHD and Leukemia with Oral BDP http://bit.ly/9uxbk9
19 May 2010
Soligenix $SNGX Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral BDP http://bit.ly/dc341U
17 May 2010
Soligenix $SNGX Reports First Quarter 2010 Financial Results and
Reviews Accomplishments http://www.soligenix.com/news.aspx?titleId=348
12 May 2010
Soligenix $SNGX completes patient enrollment in Phase 2 Acute GVHD Prevention clinical trial http://www.soligenix.com/news.aspx?titleId=347
10 May 2010
Soligenix $SNGX receives European patent to treat inflammatory GI diseases with topically active steroids, http://bit.ly/dhuo6o
1 Mar 2010
Soligenix $SNGX confirmatory Phase 3 trial of orBec® for GVHD noted in Seeking Alpha, http://tiny.cc/gvhdreview
26 Feb 2010
Soligenix, $SNGX, ricin toxin vaccine, biodefense work noted in Gene Marcial's Inside Wall Street, http://tinyurl.com/insidewallst
17 Feb 2010
Soligenix, $SNGX, receives Hong Kong patent for its Lipid Polymer Micelle technology for improved oral drug delivery, http://tiny.cc/LPM
3 Feb 2010
Soligenix, $SNGX, will present at BIO CEO & Investor Conference, http://soligenix.com/news.aspx?titleId=343
2 Feb 2010
Soligenix, $SNGX, notes positive long-term stability results with RiVax, its vaccine against ricin toxin, http://tiny.cc/rivaxvacc
6 Jan 2010
Soligenix, $SNGX, publishes positive results with RiVax, its vaccine against ricin toxin, http://soligenix.com/news.aspx?titleId=341
21 Dec 2009
Soligenix $SNGX initiates Phase 1/2 clinical trial for prevention of acute radiation enteritis http://soligenix.com/news.aspx?titleId=340